| [1] |
Spolverato G, Vitale A, Cucchetti A, et al. Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?[J]. Cancer, 2015, 121(22): 3998-4006.
|
| [2] |
Yang H, Zhou J, Wei X, et al. Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: adjuvant therapy is a favorable prognostic factor[J]. Mol Clin Oncol, 2014, 2(6): 1069-1075.
|
| [3] |
Mao ZY, Guo XC, Su D, et al. Prognostic factors of cholangio-carcinoma after surgical resection: A retrospective study of 293 patients[J]. Med Sci Monit, 2015, 21: 2375-2381.
|
| [4] |
Cheng CT, Chu YY, Yeh CN, et al. Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma[J]. Onco Targets Ther, 2015, 8: 1899-1907.
|
| [5] |
Howell M, Valle JW. The role of adjuvant chemotherapy and radiotherapy for cholangiocarcinoma[J]. Best Pract Res Clin Gastroenterol, 2015, 29(2): 333-343.
|
| [6] |
Cai JP, Chen W, Hou X, et al. Simvastatin enhances the chemotherapeutic efficacy of S-1 against bile duct cancer: E2F-1/TS downregulation might be the mechanism[J]. Anticancer Drugs, 2013, 24(10): 1020-1029.
|
| [7] |
Chen C, Stock JL, Liu X, et al. Utility of a novel Oatp1b2 knockout mouse model for evaluating the role of Oatp1b2 in the hepatic uptake of model compounds[J]. Drug Metab Dispos, 2008, 36(9): 1840-1845.
|
| [8] |
Wang ST, Ho HJ, Lin JT, et al. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells[J]. Cell Death Dis, 2017, 8(2): e2626.
|
| [9] |
Wang F, Liu W, Ning J, et al. Simvastatin suppresses proliferation and migration in non-small cell lung cancer via pyroptosis[J]. Int J Biol Sci, 2018, 14(4): 406-417.
|
| [10] |
Ibrahim AB, Zaki HF, Ibrahim WW, et al. Evaluation of tamoxifen and simvastatin as the combination therapy for the treatment of hormonal dependent breast cancer cells[J]. Toxicol Rep, 2019, 6: 1114-1126.
|
| [11] |
Liu Q, Xia H, Zhou S, et al. Simvastatin inhibits the malignant behaviors of gastric cancer cells by simultaneously suppressing YAP and β-catenin signaling[J]. Onco Targets Ther, 2020, 13: 2057-2066.
|
| [12] |
Lu L, Huang W, Hu W, et al. Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer[J]. Biochem Biophys Res Commun, 2019, 511(4): 772-779.
|
| [13] |
Wang G, Cao R, Wang Y, et al. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway[J]. Sci Rep, 2016, 6: 35783.
|
| [14] |
Lee SJ, Lee I, Lee J, et al. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer[J]. Br J Cancer, 2014, 111(3): 497-505.
|
| [15] |
Islam M, Sharma S, Kumar B, et al. Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis[J]. Oral Oncol, 2013, 49(8): 778-786.
|
| [16] |
Zhang J, Yang Z, Xie L, et al. Statins, autophagy and cancer metastasis[J]. Int J Biochem Cell Biol, 2013, 45(3): 745-752.
|
| [17] |
Luput L, Sesarman A, Porfire A, et al. Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5-fluorouracil in vivo[J]. Cancer Sci, 2020, 111(4): 1344-1356.
|
| [18] |
Taylor-Harding B, Orsulic S, Karlan BY, et al. Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells[J]. Gynecol Oncol, 2010, 119(3): 549-556.
|
| [19] |
Jamil A, Aamir Mirza M, Anwer MK, et al. Co-delivery of gemcitabine and simvastatin through PLGA polymeric nanoparticles for the treatment of pancreatic cancer: in-vitro characterization, cellular uptake, and pharmacokinetic studies[J]. Drug Dev Ind Pharm, 2019, 45(5): 745-753.
|
| [20] |
Hasegawa S, Mukai M, Sato S, et al. Long-term survival and tumor 5-FU sensitivity in patients with stage IV colorectal cancer and peritoneal dissemination[J]. Oncol Rep, 2006, 15(5): 1185-1190.
|
| [21] |
Edler D, Hallström M, Ragnhammar P, et al. Thymidylate synthase expression in rectal cancer and proliferation, assessed by cyclin A and Ki-67 expression[J]. Anticancer Res, 2002, 22(5): 3113-3116.
|
| [22] |
Henslee AB, Steele TA. Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia[J]. Biomark Res, 2018, 6: 26.
|